-
Signature
-
/s/ Stacie S. Aarestad, Attorney-in-Fact
-
Stock symbol
-
ORGO
-
Transactions as of
-
Dec 15, 2021
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
12/17/2021, 08:00 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ORGO |
Class A Common Stock |
Gift |
$0 |
-5.42M |
-8.35% |
$0.00 |
59.4M |
Dec 15, 2021 |
By the Dennis Erani 2014 GRAT |
F1, F2 |
transaction |
ORGO |
Class A Common Stock |
Gift |
$0 |
+5.42M |
+10.03% |
$0.00 |
59.4M |
Dec 15, 2021 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom and certain of their respective affiliates, including Organo PFG LLC, Organo Investors LLC, Dennis Erani 2012 Issue Trust, Alan Ades as Trustee of the Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, GN 2016 Family Trust u/a/d August 12, 2016 and GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, referred to collectively as the "Group", are parties to a Controlling Stockholders' Agreement dated December 10, 2018 with Organogenesis Holdings Inc. (the "Stockholders' Agreement"). The Stockholders' Agreement, among other things, provides for nomination rights of the Group with respect to four directors of the Issuer. As a result of the Stockholders' Agreement, the reporting persons may be deemed to be members of a group holding over 10% of the outstanding shares of common stock of the issuer for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. This is Form 4 No. 2 of 2 filed for the Group.